Drug details
Vocabria (cabotegravir tablets for oral use)
type of HIV, Integrase Inhibitors
Vocabria (cabotegravir) is a human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor (INSTI) indicated in combination with Edurant (rilpivirine) for short-term treatment of HIV-1 infection in adults who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine, for use as oral lead-in to assess the tolerability of cabotegravir prior to administration of Cabenuva (cabotegravir; rilpivirine) extended-release injectable suspensions and for use as oral therapy for patients who will miss planned injection dosing with Cabenuva.
The drug is often used to treat HIV .
This drug may have the following side effects:
- clay-colored stools, and
- nausea,
- vomiting,
- muscle or joint pain,
- loss of appetite,
- fever,
- rash,
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- extreme tiredness,
- feeling unwell,
- blisters or sores in or around your mouth,
- red or puffy eyes,
- stomach pain (upper right side),
- dark urine,
- severe dizziness,
- thoughts of self-harm,
- unusual mood changes (sadness, hopeless, anxiety, or restless),
- yellowing of the skin or eyes
The following drugs are related to Vocabria, either as a replacement or used together:
- Ziagen (abacavir sulfate)
- Epzicom (abacavir sulfate and lamivudine tablets)
- Trizivir (abacavir sulfate, lamivudine, and zidovudine)
- Triumeq (abacavir, dolutegravir, and lamivudine film-coated tablets)
- Aptivus (tipranavir)
- Evotaz (atazanavir and cobicistat tablets for oral administration)
- Reyataz (atazanavir sulfate)
- Atripla (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)
- Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide tablets)
- Cabenuva (cabotegravir; rilpivirine extended-release injectable suspension)
- Cimduo (lamivudine and tenofovir disoproxil fumarate tablets, for oral use)
- Tybost (cobicistat tablets)
- Combivir (lamivudine, zidovudine)
- Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate tablets)
- Prezista (darunavir)
- Prezcobix (darunavir and cobicistat tablets)
- Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide tablets)
- Delstrigo (doravirine, lamivudine, and tenofovir disoproxil fumarate tablets)
- Descovy (emtricitabine and tenofovir alafenamide tablets)
- Dovato (dolutegravir and lamivudine tablets)
- Juluca (dolutegravir and rilpivirine tablets, for oral use)
- Pifeltro (doravirine tablets)
- Tivicay (doutegravir 50mg tablets)
- Sustiva (efavirenz)
- Emtriva (emtricitabine)
- Truvada (emtricitabine tenofovir df)
- Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide fixed-dose combination tablets)
- Fuzeon (enfuvirtide)
- Epivir (lamivudine)
- Epivir-HBV (lamivudine tablets and oral solution)
- Intelence (etravirine tablets)
- Lexiva (fosamprenavir calcium)
- Rukobia (fostemsavir extended-release tablets)
- Trogarzo (ibalizumab-uiyk injection)
- Invirase (saquinavir mesylate)
- Isentress (raltegravir tablets)
- Kaletra Capsules (lopinavir, ritonavir capsules)
- Kaletra Tablets (lopinavir, ritonavir tablets)
- Selzentry (maraviroc)
- Viramune (nevirapine)
- Viramune XR (nevirapine extended-release tablets, for oral use)
- Retrovir (zidovudine)
- Retrovir IV (zidovudine injection)
- Viread (tenofovir disoproxil fumarate)